Skip to main content
Sansure Biotech Inc. logo

Sansure Biotech Inc. — Investor Relations & Filings

Ticker · 688289 ISIN · CNE1000043J1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 871 across all filing types
Latest filing 2022-08-19 Major Shareholding Noti…
Country CN China
Listing Shanghai Stock Exchange 688289

About Sansure Biotech Inc.

https://www.sansureglobal.com/

Sansure Biotech Inc. specializes in the development and manufacture of molecular diagnostic products and genetic testing solutions. The company utilizes proprietary technologies, such as the "One-tube" fast extraction method and advanced magnetic bead technology, to provide high-sensitivity PCR diagnostic kits. Its product portfolio covers a wide range of clinical applications, including infectious disease screening for hepatitis, respiratory infections, and sexually transmitted infections, as well as oncology and maternal health. Sansure also provides integrated laboratory automation systems, including nucleic acid extractors and real-time PCR instruments, designed to streamline clinical workflows and improve diagnostic efficiency for healthcare providers and research institutions globally.

Recent filings

Filing Released Lang Actions
圣湘生物科技股份有限公司关于持股5%以上股东部分股份解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement from 圣湘生物科技股份有限公司 regarding the partial release of pledged shares by a shareholder holding more than 5% of the company's shares. It details the number of shares released from pledge, the remaining pledged shares, and the shareholder's total holdings. The content focuses on share pledge status and changes, not on financial results, management changes, or other report types. The document length is short (838 characters), and it is a specific shareholder-related announcement about share pledge status. This fits best under the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership or related shareholding matters such as pledges or releases thereof.
2022-08-19 Chinese
圣湘生物科技股份有限公司首次公开发行战略配售限售股上市流通公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the listing and circulation of restricted shares (strategic placement restricted shares) following the company's initial public offering. It details the number of shares becoming freely tradable, the lock-up period, shareholder commitments, and regulatory compliance. It does not contain financial statements or detailed financial performance data, nor is it a report or presentation. The document is a formal announcement about the change in share status and circulation, specifically about restricted shares becoming tradable. This fits the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes such as restricted shares becoming tradable.
2022-08-19 Chinese
圣湘生物科技股份有限公司关于自愿披露公司相关检测产品获得英国MHRA认证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the voluntary disclosure of a product obtaining UK MHRA certification. It includes details about the product, its certification, usage scope, and risk warnings related to market competition and profit impact uncertainty. The document is short (1298 characters) and does not contain financial statements, management discussion, or detailed financial data. It is an official announcement about a regulatory certification event rather than a financial report or management update. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-08-19 Chinese
圣湘生物科技股份有限公司关于持股5%以上股东、时任董事回购股份结果公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement regarding the completion of a share repurchase plan by a significant shareholder and director of the company. It details the number of shares repurchased, the payment amount, adjustments due to capital increases, and compliance with regulatory requirements. There are no financial statements or comprehensive financial data presented, nor is this a report or presentation. The content fits the description of a Transaction in Own Shares (POS) filing, which reports on the company's or insiders' buyback or sale of shares.
2022-08-18 Chinese
圣湘生物科技股份有限公司关于自愿披露公司相关产品获得美国FDA认证的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from the company 圣湘生物科技股份有限公司 regarding the voluntary disclosure of its product obtaining FDA certification. It details the product description, certification details, potential market competition risks, and uncertainty about profit impact. The document is relatively short (1375 characters) and does not contain financial statements, management discussion, or detailed financial data. It is an announcement about a regulatory approval event rather than a financial report or management update. Therefore, it fits best into the category of Regulatory Filings (RNS), which is a fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-08-18 Chinese
圣湘生物科技股份有限公司持股5%以上股东集中竞价减持股份计划公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement regarding a major shareholder's plan to reduce their holdings through centralized bidding. It details the shareholder's current holdings, past reductions, planned reduction quantities, and compliance with relevant securities laws and regulations. The document does not contain financial statements or detailed financial performance data, nor is it a report or presentation. It is a regulatory announcement about a significant shareholding change by a shareholder holding more than 5% of shares. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length is under 5,000 characters and is a standalone announcement, not a report publication or certification.
2022-08-16 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.